Cross Country Healthcare Inc. (NASDAQ:CCRN) has a beta of 1.17, a 12-month trailing P/E ratio of 77.28, and a growth ratio of 6.96. The stock’s Relative Strength Index (RSI) is 67.96, with weekly volatility at 4.77% and ATR at 0.82. The CCRN stock’s 52-week price range has touched low of $5.46 and a $17.39 high. Its shares traded higher over the last trading session, gaining 1.82% on 06/10/21. The shares fell to a low of $16.48 before closing at $17.31. Intraday shares traded counted 0.48 million, which was -98.88% lower than its 30-day average trading volume of 239.53K. CCRN’s previous close was $17.00 while the outstanding shares total 36.18M.
Investors have identified the Staffing & Employment Services company Cross Country Healthcare Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $657.61 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cross Country Healthcare Inc. (CCRN) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 269.73 million total, with 121.66 million as their total liabilities.
CCRN were able to record -26.11 million as free cash flow during the 08/04/2021 quarter of the year, this saw their quarterly net cash flow reduce by 11.89 million. In cash movements, the company had a total of -24.93 million as operating cash flow.
Potential earnings growth for Cross Country Healthcare Inc. (CCRN)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/04/2021 quarter of the year, Cross Country Healthcare Inc. recorded a total of 329.24 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 36.2% coming in sequential stages and their sales for the 08/04/2021 quarter increasing by 34.51%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 257.78 million trying to sell their products during the last quarter, with the result yielding a gross income of 71.47 million. This allows shareholders to hold on to 36.18M with the recently reported earning now reading 0.54 cents per share. This is a figure that compared to analyst’s prediction for their 08/04/2021 (0.58 cents a share).
Having a look at the company’s valuation, the company is expected to record 0.68 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CCRN sounds very interesting.
Is the stock of CCRN attractive?
In related news, President, CEO, Clark Kevin Cronin bought 9,101 shares of the company’s stock in a transaction that recorded on Aug 31. The purchase was performed at an average price of 6.29, for a total value of 57,245. As the purchase deal closes, the President, CEO, Clark Kevin Cronin now bought 2,389 shares of the company’s stock, valued at 14,860. Also, Director, CASH W LARRY bought 5,000 shares of the company’s stock in a deal that was recorded on Aug 13. The shares were cost at an average price of 6.61 per share, with a total market value of 33,050. Following this completion of disposal, the Vice President of Operations, Saville Stephen Alexis now holds 2,000 shares of the company’s stock, valued at 11,480. In the last 6 months, insiders have changed their ownership in shares of company stock by 3.90%.
3 out of 8 analysts covering the stock have rated it a Buy, while 4 have maintained a Hold recommendation on Cross Country Healthcare Inc.. 0 analysts has assigned a Sell rating on the CCRN stock. The 12-month mean consensus price target for the company’s shares has been set at $15.42.